Does LEVETIRACETAM Cause Tonsillar hypertrophy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Tonsillar hypertrophy have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.0% of all adverse event reports for LEVETIRACETAM.
10
Reports of Tonsillar hypertrophy with LEVETIRACETAM
0.0%
of all LEVETIRACETAM reports
0
Deaths
7
Hospitalizations
How Dangerous Is Tonsillar hypertrophy From LEVETIRACETAM?
Of the 10 reports, 7 (70.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Tonsillar hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does LEVETIRACETAM Cause?
Seizure (9,961)
Drug ineffective (8,666)
Off label use (5,789)
Maternal exposure during pregnancy (3,197)
Foetal exposure during pregnancy (2,604)
Epilepsy (2,546)
Generalised tonic-clonic seizure (2,276)
Somnolence (2,070)
Fatigue (1,972)
Status epilepticus (1,883)
What Other Drugs Cause Tonsillar hypertrophy?
ADALIMUMAB (151)
ONDANSETRON (51)
SOMATROPIN (43)
SECUKINUMAB (42)
DUPILUMAB (39)
METHOTREXATE (39)
INFLIXIMAB (31)
TACROLIMUS (26)
INFLIXIMAB-DYYB (25)
ETANERCEPT (24)
Which LEVETIRACETAM Alternatives Have Lower Tonsillar hypertrophy Risk?
LEVETIRACETAM vs LEVOBUNOLOL
LEVETIRACETAM vs LEVOBUPIVACAINE
LEVETIRACETAM vs LEVOCARNITINE
LEVETIRACETAM vs LEVOCETIRIZINE
LEVETIRACETAM vs LEVODOPA